Verona to test COPD hopeful ensifentrine in COVID-19 patientsVerona Pharma is starting a pilot study of its inhaled respiratory diseases drug ensifentrine in patients hospitalised with Share XVerona to test COPD hopeful ensifentrine in COVID-19 patientshttps://pharmaphorum.com/news/verona-to-test-copd-hopeful-ensifentrine-in-covid-19-patients/
